Safety and Pharmacokinetics of Oral Controlled-ileocolonic-release Nicotinamide (CICR-NAM)

NCT05258474 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Safety Issues
Pharmacokinetic

Interventions

DRUG: controlled-ileocolonic-release nicotinamide (SAD/MAD/MD)
DRUG: Immediate-release nicotinamide (SAD)
DRUG: Placebo controlled-ileocolonic-release nicotinamide (SAD/MAD)
DRUG: Placebo Immediate-release nicotinamide (SAD)

Sponsor

University Hospital Schleswig-Holstein